Hadasit sells stem cell co Cell Cure stake – Globes
Globes |
Hadasit sells stem cell co Cell Cure stake
Globes BioTime decided to acquire full ownership of Cell Cure after it published in early May initial results for a number of people who participated in trial of its stem cell implants. These trials found that the cells were well received in the patients … |
